Aster DM Healthcare, a major UAE healthcare provider, is pioneering a revolutionary approach to neurological and pediatric rehabilitation through the deployment of over 21 FDA-approved robotic systems across its facilities this year. These advanced medical technologies represent a significant leap forward in treating stroke survivors, spinal injury patients, and children with developmental conditions.
The robotic systems, described by Managing Director and Group CEO Alisha Moopen as ‘next level’ technology, work in collaboration with neurosurgeons and physiotherapists to retrain the brain by rebuilding damaged neural connections. ‘There are people who have just given up complete hope after certain injuries,’ Moopen stated. ‘There is a chance that they will be able to walk again.’
Among the most groundbreaking innovations is the world’s first pediatric rehabilitation robot scheduled for introduction in Dubai later this year. This specialized technology will support children with ADHD and other developmental challenges through integrated brain mapping, virtual reality immersion therapy, and targeted neural stimulation. Moopen emphasized that this advancement ‘will change the way we talk about child behaviors, child psychology and child development issues.’
Concurrent with its technological expansion, Aster DM Healthcare is significantly growing its physical infrastructure. The group will open two new multi-specialty hospitals in Dubai’s Studio City and Discovery Gardens areas, adding over 250 beds to their current approximately 920-bed UAE capacity. Additionally, plans are underway to expand Aster Hospital in Al Qusais with 122 operational beds.
Moopen attributed this expansion to demographic shifts rather than increased illness rates. ‘It’s not that people are getting sicker; it’s that people are living longer,’ she explained. ‘When your length of life has increased, the requirement for healthcare increases.’ This longevity trend has created new demand for geriatric care services, with the UAE seeing more retirees choosing to settle in the country.
Complementing these developments, Aster launched the Thrive system—a comprehensive preventive health assessment that tests for 100 biomarkers including blood health, cardiac function, metabolism, hormones, inflammation, and nutritional status. This proactive health monitoring platform will integrate with major wearable devices and the myAster app, enabling physicians to provide personalized insights and preventive recommendations for long-term wellbeing.